Analyst Ratings for Teva Pharma (TEVA) [Buys]
TEVA Rating Summary
TEVA Price Target Summary
- Highest: $19.00 (Piper Sandler)
- Lowest: $10.00 (Morgan Stanley)
- Average: $14.22
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$14.22 (+9.3%)
* Over Last 12-Mos
Rating Score: 3.2 / 10
Percentile Rank: 28%
Rating Score: 3.2 / 10
Percentile Rank: 28%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/12/2024 | Piper Sandler | David Amsellem | Upgrade | Overweight (Neutral) |
19.00 (12.00) |
12.09 (13.01) |
7.61% | Details |
| 1/23/2024 | Jefferies » Updated 3/11/2024 |
Glen Santangelo | Upgrade | Buy (Hold) |
17.00 (16.00) |
11.18 (13.01) |
16.37% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
